Biocon
-
{
- All
- News
- Videos
-
Who Is Claire Mazumdar? Meet Kiran Mazumdar-Shaw's Chosen Successor At Biocon
Claire Mazumdar, 37, is a biotech specialist and the founding CEO of Bicara Therapeutics, a clinical-stage oncology firm incubated by Biocon.
-
Biocon Employee, 26, Found Dead At Bengaluru Office
A 26-year-old employee of Biocon was found dead on the company premises at Bengaluru's Electronic City Phase-II on Tuesday.
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Husband
Biocon executive chairperson Kiran Mazumdar Shaw this morning shared a post on Twitter remembering her husband John Shaw.
-
John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Dies At 73
John Shaw, the husband of Biocon executive chairperson Kiran Mazumdar Shaw, passed away on Monday at the age of 73.
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Case Against Joint Drugs Controller For Allegedly Taking Bribe To Clear Biocon Product
The CBI on Monday apprehended Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4-lakh bribe to clear 'Insulin Aspart', an underdevelopment product of Biocon Biologics.
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
Covid Has Created An 'Ecosystem' Of Innovation In India: Kiran Mazumdar-Shaw
The ongoing COVID-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-US bio-pharma summit in Boston next week.
-
Biocon To Spend Rs 65 Crore On Metro Station At Bengaluru's Hebbagodi
The Namma Metro project in Bengaluru received a financial boost from the city's Biocon Foundation, headed by Dr Kiran Mazumdar Shaw.
-
"Have Added To Covid Count...": Kiran Mazumdar Shaw Tests Positive
Kiran Mazumdar Shaw has tested positive for coronavirus, the chief of biopharmaceutical firm Biocon has tweeted. "I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way," Kiran Mazumdar Shaw tweeted on Monday night.
-
"Good To Be Back": Kiran Mazumdar Shaw Attends Office For First Time Since March
The Biocon chief had last attended the office on March 24. A day later, Prime Minister Narendra Modi had announced a nationwide lockdown to control the spread of coronavirus. All but essential services were shut across the country, effectively putting over a billion people indoor.
-
Who Is Claire Mazumdar? Meet Kiran Mazumdar-Shaw's Chosen Successor At Biocon
Claire Mazumdar, 37, is a biotech specialist and the founding CEO of Bicara Therapeutics, a clinical-stage oncology firm incubated by Biocon.
-
Biocon Employee, 26, Found Dead At Bengaluru Office
A 26-year-old employee of Biocon was found dead on the company premises at Bengaluru's Electronic City Phase-II on Tuesday.
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Husband
Biocon executive chairperson Kiran Mazumdar Shaw this morning shared a post on Twitter remembering her husband John Shaw.
-
John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Dies At 73
John Shaw, the husband of Biocon executive chairperson Kiran Mazumdar Shaw, passed away on Monday at the age of 73.
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Case Against Joint Drugs Controller For Allegedly Taking Bribe To Clear Biocon Product
The CBI on Monday apprehended Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4-lakh bribe to clear 'Insulin Aspart', an underdevelopment product of Biocon Biologics.
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
Covid Has Created An 'Ecosystem' Of Innovation In India: Kiran Mazumdar-Shaw
The ongoing COVID-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-US bio-pharma summit in Boston next week.
-
Biocon To Spend Rs 65 Crore On Metro Station At Bengaluru's Hebbagodi
The Namma Metro project in Bengaluru received a financial boost from the city's Biocon Foundation, headed by Dr Kiran Mazumdar Shaw.
-
"Have Added To Covid Count...": Kiran Mazumdar Shaw Tests Positive
Kiran Mazumdar Shaw has tested positive for coronavirus, the chief of biopharmaceutical firm Biocon has tweeted. "I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way," Kiran Mazumdar Shaw tweeted on Monday night.
-
"Good To Be Back": Kiran Mazumdar Shaw Attends Office For First Time Since March
The Biocon chief had last attended the office on March 24. A day later, Prime Minister Narendra Modi had announced a nationwide lockdown to control the spread of coronavirus. All but essential services were shut across the country, effectively putting over a billion people indoor.
